1Fareed J, Hoppensteadt DA. Pharmacology of the low - molecular - weight heparins. Semin Thromb Hemost, 1996,22 ( suppl 2) : 13 -18.
2JHom, R J deHaan, M. Vermeulen, et al. NimodiPine in ani - malmodel experiments of focal cerebral isehemia: A systematic re -view[J]. Stroke,2001,32(10) :2433.
6J Horn,R J de Haan,M.Vermeulen,et al.Nimodipine in animal model experiments of focal cerebral ischemia:A systematic review[J].Stroke,2001,32 (10):2433.
7Wolf-R,Schabitz,Fuhai Li,et al.The N-Methyl-D-Aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats[J].Stroke,2000,31 (7):1709.
8De Vry J,Horvath E,Schreiber R.Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620[J].Eur J Pharmacol,2001,428(2):203.
9Bao WL,Williams A J,Faden AI,et al.Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia[J].Brain Res,2001,922(2).
10Ann Bond,Nicole M Jones,Caroline A,et al.Neuroprotective effects LY379268,a selective mGlu2/3 receptor agonist:investigations into possible mechanism of action in vivo[J].JPET,2000,294(3):800.
